Hearing: Examining Drug-Impaired Driving

The House Committee on Energy and Commerce, Subcommittee on Digital Commerce and Consumer Protection, will hold a hearing titled "Examining Drug-Impaired Driving." The following issues may be examined at the hearing:

  • The current trends of drug-impaired driving, including the size and scope of the problem.
  • What states are currently doing to address drug-impaired driving, including law enforcement action and training, roadside detection capabilities, and public education.
  • Whether there is enough accurate available data on drug-impaired driving and what can be done to improve data collection.
  • Ways in which the federal government can help address the growing problem, including NHTSA’s Drug-Impaired Driving Initiative.
  • How to respond to the public safety risks posed by drug-impaired driving and any policy recommendations for both state and federal action moving forward.

Witnesses include: 

  • Dr. Robert L. DuPont: President, Institute for Behavior and Health
  • Ms. Jennifer Harmon: Assistant Director, Forensic Chemistry, Orange County Crime Lab
  • Ms. Erin Holmes: Director, Traffic Safety Programs and Technical Writer, Responsibility.org
  • Ms. Colleen Sheehy-Church: National President, Mothers Against Drunk Driving

Members of the public may attend in person or via webcast. More information is available at the Committee's website.

Event Date
Wednesday, July 11, 2018 - 1:00pm
Topics
Neuroscience